{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-24-004417","form_type":"8-K","ticker":"PHIO","cik":"0001533040","company_name":"Phio Pharmaceuticals Corp.","filed_at":"2024-06-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.873034+00:00","generated_at":"2026-06-01T02:50:10.596809+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Phio shareholders approve reverse stock split (1:2-1:9) and 500K share increase to LTIP","bullets":["Reverse stock split proposal approved with 1,879,666 For, 313,572 Against; board to set exact ratio and effective date.","Amendment to 2020 Long Term Incentive Plan approved, increasing shares by 500,000 to total 725,500.","All five director nominees elected: Bitterman, Bradford, Ferrara, Freeman, Lockshin, each with >559K For votes.","Ratification of BDO USA as independent auditor for FY 2024 approved with 2,075,307 For votes."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-24-004417","json":"https://secwatch.observer/filing/0001683168-24-004417.json","markdown":"https://secwatch.observer/filing/0001683168-24-004417.md","text":"https://secwatch.observer/filing/0001683168-24-004417.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533040/000168316824004417/0001683168-24-004417-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533040/000168316824004417/phio_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T02:50:10.596809+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}